All Stories

  1. Aqueous flare dynamics following penetrating, anterior lamellar, and endothelial corneal transplantation: Quantitative comparison and early complication detection
  2. Epidemiology of Uveitis and Extra-Uveal Inflammation in a Referral Center in Central Italy
  3. AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
  4. Corrigendum to Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection
  5. Alcohol delamination and topical mitomycin-C 0.02% for the treatment of corneal intraepithelial neoplasia
  6. Enhancing Visual Quality: The Impact of Alcohol-Assisted Delamination on Corneal Aberrations in Patients with Central Epithelial Basement Membrane Dystrophy
  7. Safety of intravitreal injections with the mobile laminar airflow device Operio after more than 10.000 injections
  8. Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)
  9. Combined Multilayered Amniotic Membrane Graft and Fibrin Glue as a Surgical Management of Limbal Dermoid Cyst
  10. Mobile unidirectional airflow device reduces air contamination in an intravitreal outpatient clean room setting
  11. Optic disc pit maculopathy: Covering or filling technique with human amniotic membrane patch to treat the optic disc pit maculopathy?
  12. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  13. TENAYA and LUCERNE
  14. Predictive Role of Fluorescein Angiography in Retinopathy of Prematurity
  15. Faricimab Treat-and-Extend for Diabetic Macular Edema
  16. Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity
  17. Combined superficial keratectomy, alcohol delamination and amniotic membrane patch with fibrin glue in Salzmann nodular degeneration
  18. Increasing incidence of contact-lens-related Acanthamoeba keratitis in a tertiary ophthalmology department in an Italian population
  19. Chloroprocaine 3% Gel as a Novel Ocular Topical Anesthetic: Results from a Multicenter, Randomized Clinical Trial in Patients Undergoing Cataract Surgery
  20. Choroidal vascularity analysis in patients with juvenile idiopathic arthritis without acute uveitis
  21. Clinical evaluation of tear substitute utility after anti-VEGF intravitreal injection
  22. Efficacy and Safety of PreserFlo MicroShunt Implantation and Its Effects on Intraocular Inflammation through Laser Flare Photometry
  23. Cardiolipin-mediated temporal response to hydroquinone toxicity in human retinal pigmented epithelial cell line
  24. Bilateral evolution of OCT biomarkers in dry AMD: Long-term follow up study
  25. New insights on circumscribed choroidal hemangioma: “bench to bedside”
  26. Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial
  27. Risk of retinal vein occlusion following COVID-19 vaccination: a self-controlled case series
  28. Choroidal vascularity profile in diabetic eyes using wide field optical coherence tomography
  29. Evaluation of warm compresses and topical cyclosporine treatment in meibomian gland dysfunction by confocal scanning laser microscopy
  30. Primary small gauge pars plana vitrectomy and silicone oil endotamponade for endophthalmitis after cataract surgery: Clinical and OCT findings
  31. Biologic therapies for juvenile idiopathic arthritis-associated uveitis
  32. Improvement of retinal OCT angiograms by Sampling Kantorovich algorithm in the assessment of retinal and choroidal perfusion
  33. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity
  34. Correction to: Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  35. Treatment of Open-Angle Glaucoma and Ocular Hypertension with the Fixed-Dose Combination of Preservative-Free Tafluprost/Timolol: Clinical Outcomes from Ophthalmology Clinics in Italy
  36. Switching to Preservative-Free Tafluprost/Timolol Fixed-Dose Combination in the Treatment of Open-Angle Glaucoma or Ocular Hypertension: Subanalysis of Data from the VISIONARY Study According to Baseline Monotherapy Treatment
  37. In-vivo visualization of the photoreceptors using Spectralis High Magnification Module imaging in central serous chorioretinopathy
  38. Choroidal vasculature analysis in MEK inhibitor-associated retinopathy
  39. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
  40. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
  41. New trends in intravitreal anti-VEGF therapy for ROP
  42. Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study
  43. Wide-field optical coherence tomography imaging in diabetic retinopathy
  44. Dry eye and inflammation of the ocular surface after cataract surgery: effectiveness of a tear film substitute based on trehalose/hyaluronic acid vs hyaluronic acid to resolve signs and symptoms
  45. Phase 3, Randomized, 20-Month Study of the Efficacy and Safety of Bimatoprost Implant in Patients with Open-Angle Glaucoma and Ocular Hypertension (ARTEMIS 2)
  46. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  47. Corneal and Epithelial Thickness Mapping: Comparison of Enhanced Spectral-Domain- and Spectral-Domain-Optical Coherence Tomography
  48. The choroidal rupture: current concepts and insights
  49. Real‐world outcomes of anti‐VEGF therapy in treatment‐naïve neovascular age‐related macular degeneration diagnosed on OCT angiography: the REVEAL study
  50. Comparison of two different scleral fixation techniques of posterior chamber Carlevale lens
  51. Kinetics of hydrocortisone sodium phosphate penetration into the human aqueous humor after topical application
  52. Intraretinal, sub-retinal, and sub-retinal pigmented epithelium fluid in non-exudative age-related macular degeneration: follow-up with OCT imaging
  53. Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
  54. Sildenafil in Ophthalmology: An update
  55. Trehalose/sodium hyaluronate eye drops in post-cataract ocular surface disorders
  56. Novel noninvasive biomarkers of prodromal Alzheimer disease: The role of optical coherence tomography and optical coherence tomography–angiography
  57. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  58. Drusen ooze: Predictor for progression of dry age-related macular degeneration
  59. Functional expression and localisation of HOPS/TMUB1 in mouse lens
  60. A novel approach for scleral fixation using Carlevale lens
  61. Central serous chorioretinopathy imaging biomarkers
  62. Wide-field choroidal vascular analysis in central serous chorioretinopathy
  63. OCT-Angiography as a reliable prognostic tool in laser-treated proliferative diabetic retinopathy: The RENOCTA Study
  64. Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi—the SON study
  65. Xen Gel Stent as a minimally invasive option for intraocular pressure control after DSAEK: A case study
  66. Factors predicting normal visual acuity following anatomically successful macular hole surgery
  67. Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence
  68. Epi-off-lenticule-on corneal collagen cross-linking in thin keratoconic corneas
  69. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial
  70. Intravitreal dexamethasone implant one month before versus concomitant with cataract surgery in patients with diabetic macular oedema: the dexcat study
  71. Correction to: Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  72. Effect of preoperative topical nepafenac 0.1% on inflammatory response after uncomplicated cataract surgery in healthy subjects
  73. Wide-field individual retinal layer thickness in healthy eyes
  74. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  75. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  76. Functional correlation between choroidal and retinal vascularity in low-grade diabetic retinopathy
  77. Chronic Neovascular Central Serous Chorioretinopathy: A Stress/Rest Optical Coherence Tomography Angiography Study
  78. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study
  79. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study
  80. Comparison of anti-inflammatory effects of eye drops formulations after uncomplicated cataract surgery
  81. Efficacy of topical microemulsion of fatty acids of the ω-3 series on the sub-epithelial corneal nerves regeneration after epithelium-off corneal collagen cross-linking for keratoconus
  82. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results
  83. The Effectiveness of 0.6% Povidone Iodine Eye Drops in Reducing the Conjunctival Bacterial Load and Needle Contamination in Patients Undergoing Anti-VEGF Intravitreal Injection: A Prospective, Randomized Study
  84. Safety of 6000 intravitreal dexamethasone implants
  85. Efficacy of Three Different Prophylactic Treatments for Postoperative Nausea and Vomiting after Vitrectomy: A Randomized Clinical Trial
  86. Inhibition of platelet function after ocular administration of non-steroidal anti-inflammatory drugs
  87. New insight on choroidal vasculature: multimodal morphofunctional approach
  88. Wide-field choroidal thickness profile in healthy eyes
  89. Correlation of central and peripheral keratometric parameters after corneal collagen cross-linking in keratoconus patients
  90. Intraocular lens dislocation: a novel in-situ scleral refixation technique using a 25 Gauge trocar in the anterior chamber
  91. Retinal Vascular Reactivity in Central Serous Chorioretinopathy
  92. Wide-field Choroidal Vascularity in Healthy Eyes
  93. New Insights On Ocular Sarcoidosis: An Optical Coherence Tomography Angiography Study
  94. Choroidal Vascular Reactivity in Central Serous Chorioretinopathy
  95. Corneal incision width after lens implantation: Comparing delivery systems
  96. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
  97. Confocal scanning laser microscopy in patients with postoperative endophthalmitis
  98. Optical coherence tomography angiography in age-related macular degeneration: The game changer
  99. Binocular cyclotorsion in superior vestibular neuritis
  100. Microbubble technique in failed deep anterior lamellar keratoplasty: 2-year outcomes
  101. Optical Coherence Tomography Angiography in Healthy Subjects and Diabetic Patients
  102. Reply to Comment on: ‘Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine’
  103. Bimanual microincision cataract surgery with implantation of the new Incise® MJ14 intraocular lens through a 1.4 mm incision
  104. Visual pathway involvement in multiple sclerosis: Look straight in the eyes
  105. Tear Film Stability in Sjögren Syndrome Patients Treated with Hyaluronic Acid Versus Crosslinked Hyaluronic Acid-Based Eye Drops
  106. Ocular and oto-syphilis: not a thing of the past
  107. Inflammatory Choroidal Neovascularization: Beyond the Intravitreal Approach
  108. Red reflex screening highly sensitive for anterior segment abnormalities
  109. A recent finding in Fuchs uveitis: choroidal thinning
  110. Depth-Resolved Imaging of Papillary Vitreoretinal Neovascularization
  111. Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine
  112. Aqueous Humor Antimicrobial Activity: In Vitro Analysis after Topical 0.5% Chloramphenicol Application
  113. Retinal Microvasculature in Nonproliferative Diabetic Retinopathy: Automated Quantitative Optical Coherence Tomography Angiography Assessment
  114. Associations of Alzheimer rsquo s disease with macular degeneration
  115. Optical Coherence Tomography Angiography in Macular Edema
  116. Transient therapeutic effect of vitrectomy in primary intraocular lymphoma
  117. Red reflex examination in neonates: evaluation of 3 years of screening
  118. Outer Retinal and Choroidal Evaluation in Multiple Evanescent White Dot Syndrome (MEWDS): An Enhanced Depth Imaging Optical Coherence Tomography Study
  119. Diabetic maculopathy: Confrontation of FA and OCT‐A findings
  120. Deep inside Multifocal Choroiditis: an Optical Coherence Tomography Angiography approach
  121. Full-thickness choroidal thinning as a feature of Fuchs Uveitis Syndrome: quantitative evaluation of the choroid by Enhanced Depth Imaging Optical Coherence Tomography in a cohort of consecutive patients
  122. Automated Quantitative Analysis of Retinal Microvasculature in Normal Eyes on Optical Coherence Tomography Angiography
  123. Effect of connexin 43 inhibition by the mimetic peptide Gap27 on corneal wound healing, inflammation and neovascularization
  124. ‘False-friend’ images on optical coherence tomography angiography: early choroidal neovascularization or artefact?
  125. A case of unilateral circumscribed posterior keratoconus evaluated by three different imaging tools: optical coherence tomography, videokeratography, and Scheimpflug corneal tomography
  126. Hypotonic Maculopathy Secondary to Scleral Defect in Atypical Retinochoroidal Coloboma
  127. Biodegradable collagen matrix implant versus mitomycin-C in trabeculectomy: five-year follow-up
  128. Endoscopic dacryocystorhinostomy with and without silicone intubation: 4 years retrospective study
  129. Prevalence of hemostatic alterations in patients with recurrent spontaneous subconjunctival hemorrhage
  130. Sliding Keratoplasty Followed by Transepithelial Iontophoresis Collagen Cross-linking for Pellucid Marginal Degeneration
  131. Canaloplasty: Current Value in the Management of Glaucoma
  132. Optical Coherence Tomography Angiography of a Choroidal Neovascularization in Adult Onset Foveomacular Vitelliform Dystrophy: Pearls and Pitfalls
  133. Dexamethasone Disodium Phosphate Penetration Into the Human Aqueous Humor After Topical Application
  134. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VERSUS TRADITIONAL MULTIMODAL IMAGING IN ASSESSING THE ACTIVITY OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  135. Anterior Corneal Surface Irregularity after Descemet-Stripping Endothelial Keratoplasty for Bullous Keratopathy
  136. Reasons for Visits to an Emergency Center and Hemostatic Alterations in Patients with Recurrent Spontaneous Subconjunctival Hemorrhage
  137. A superfusion apparatus for ex vivo human eye irritation investigations
  138. Retinopathy during interferon-β treatment for multiple sclerosis: case report and review of the literature
  139. Chloramphenicol, reaches effective concentrations against several germs.
  140. Repeatability of Retinal Macular Thickness Measurements in Healthy Subjects and Diabetic Patients with Clinically Significant Macular Edema: Evaluation of the Follow-Up System of Spectralis Optical Coherence Tomography
  141. Author's Replay: Correcting timolol prescribing in glaucoma management
  142. Long-term analysis of IOL stability of the Lewis technique for scleral fixation
  143. Optical Coherence Tomography Angiography during Follow-Up: Qualitative and Quantitative Analysis of Mixed Type I and II Choroidal Neovascularization after Vascular Endothelial Growth Factor Trap Therapy
  144. Repeatability of Retinal Macular Thickness Measurements in Patients with Clinically Significant Macular Edema Using Two Different Scanning Protocols of Spectralis Optical Coherence Tomography
  145. Posterior Corneal Surface Stability after Femtosecond Laser-Assisted Keratomileusis
  146. Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
  147. Post-operative endophthalmitis caused by Acremonium falciforme with orbital and extra-orbital involvement following combined cataract and glaucoma surgery: a case report
  148. Influence of Pseudophakic Lens Capsule Opacification on Spectral Domain and Time Domain Optical Coherence Tomography Image Quality
  149. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography
  150. Timolol 0.1% gel versus timolol 0.5% eyedrops in the prophylaxis of ocular hypertension after phacoemulsification surgery
  151. Unhealthy dietary patterns associated with inflammation and endothelial dysfunction in type 1 diabetes: The EURODIAB study
  152. Correction to: Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  153. Ocular penetration of topical antibiotics: study on the penetration of chloramphenicol, tobramycin and netilmicin into the anterior chamber after topical administration
  154. Repeatability and Reproducibility of Retinal Thickness Measurements in Diabetic Patients with Spectral Domain Optical Coherence Tomography
  155. Survey on retinopathy of prematurity (ROP) in Italy
  156. Do European people with type 1 diabetes consume a high atherogenic diet? 7-year follow-up of the EURODIAB Prospective Complications Study
  157. Penetration of Prulifloxacin in human aqueous humour following oral administration
  158. Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
  159. Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study
  160. Simultaneous Descemet Stripping Automated Endothelial Keratoplasty and Aphakic Iris-Fixated Intraocular Lens Implantation: A Case Series
  161. Study of Ethane Level in Exhaled Breath in Patients with Age-Related Macular Degeneration: Preliminary Study
  162. RETINAL TOXICITY OF INTRAVITREAL GENISTEIN IN A RABBIT MODEL
  163. Rituximab Treatment for Persistent Scleritis Associated with Rheumatoid Arthritis
  164. Study of alpha-lipoic acid penetration in the human aqueous after topical administration
  165. Macular Thickness Measured by Optical Coherence Tomography in a Healthy Population Before and After Uncomplicated Cataract Phacoemulsification Surgery
  166. Simultaneous determination of Ciprofloxacin and the active metabolite of Prulifloxacin in aqueous human humor by high-performance liquid chromatography
  167. Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
  168. Retinal Astrocytic Hamartoma with Associated Macular Edema: Report of Spontaneous Resolution of Macular Edema as a Result of Increasing Hamartoma Calcification
  169. Limbal anaesthesia versus topical anaesthesia for clear corneal phacoemulsification
  170. In response to comments on limbal anaesthesia for clear cornea phacoemulsification
  171. Efficacy and safety of limbal anaesthesia for clear cornea phacoemulsification
  172. Longterm results of one-site phacotrabeculectomy
  173. Post-transplant complications. cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation. Aristei C,* Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P. Bone Marrow Tr...
  174. Cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation
  175. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold
  176. Cataracts in patients submitted to bone marrow transplantation conditioned with total body irradiation
  177. Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study
  178. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM complications study
  179. Repeatability of three-day dietary records in the EURODIAB IDDM Complications Study
  180. Nutritional intake of 2868 IDDM patients from 30 centres in Europe
  181. Cardiovascular Disease and Its Risk Factors in IDDM in Europe
  182. The Relationship Between Pregnancy and Long‐term Maternal Complications in the EURODIAB IDDM Complications Study
  183. The Relationship Between Smoking and Microvascular Complications in the EURODIAB IDDM Complications Study
  184. Study of functionality of cochlear outer hair cells in patients with retinitis pigmentosa
  185. Evaluation of functionality of cochlear outer hair cells in patients with retinitis pigmentosa and in their relatives
  186. Evoked otoacoustic emissions behaviour in retinitis pigmentosa
  187. Influences of birthweight upon brainstem maturation as reflected by auditory brainstem response (ABR) evaluation